Page last updated: 2024-10-24

calmidazolium and Carcinoma, Squamous Cell

calmidazolium has been researched along with Carcinoma, Squamous Cell in 1 studies

calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pezzella, N1
Bouchot, A1
Bonhomme, A1
Pingret, L1
Klein, C1
Burlet, H1
Balossier, G1
Bonhomme, P1
Pinon, JM1

Other Studies

1 other study available for calmidazolium and Carcinoma, Squamous Cell

ArticleYear
Involvement of calcium and calmodulin in Toxoplasma gondii tachyzoite invasion.
    European journal of cell biology, 1997, Volume: 74, Issue:1

    Topics: Animals; Calcimycin; Calcium; Calcium Channel Blockers; Calmodulin; Carcinoma, Squamous Cell; Cytoso

1997